JP2016516756A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516756A5 JP2016516756A5 JP2016506681A JP2016506681A JP2016516756A5 JP 2016516756 A5 JP2016516756 A5 JP 2016516756A5 JP 2016506681 A JP2016506681 A JP 2016506681A JP 2016506681 A JP2016506681 A JP 2016506681A JP 2016516756 A5 JP2016516756 A5 JP 2016516756A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- myristoyl
- pharmaceutical composition
- peptide
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361808966P | 2013-04-05 | 2013-04-05 | |
| US61/808,966 | 2013-04-05 | ||
| PCT/US2014/033206 WO2014165853A1 (en) | 2013-04-05 | 2014-04-07 | Inhibitors of metastasis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016516756A JP2016516756A (ja) | 2016-06-09 |
| JP2016516756A5 true JP2016516756A5 (https=) | 2017-05-25 |
| JP6449849B2 JP6449849B2 (ja) | 2019-01-09 |
Family
ID=51654619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016506681A Expired - Fee Related JP6449849B2 (ja) | 2013-04-05 | 2014-04-07 | 転移のインヒビター |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US9408886B2 (https=) |
| EP (1) | EP2981279B1 (https=) |
| JP (1) | JP6449849B2 (https=) |
| KR (1) | KR102191695B1 (https=) |
| CN (1) | CN105517562B (https=) |
| AU (1) | AU2014247979B2 (https=) |
| BR (1) | BR112015025398A2 (https=) |
| CA (1) | CA2908832C (https=) |
| DK (1) | DK2981279T3 (https=) |
| ES (1) | ES2714863T3 (https=) |
| HU (1) | HUE043971T2 (https=) |
| IL (1) | IL241937B (https=) |
| MX (1) | MX363077B (https=) |
| PL (1) | PL2981279T3 (https=) |
| PT (1) | PT2981279T (https=) |
| RU (1) | RU2681213C2 (https=) |
| SG (2) | SG11201508249WA (https=) |
| WO (1) | WO2014165853A1 (https=) |
| ZA (1) | ZA201508010B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE043971T2 (hu) * | 2013-04-05 | 2019-09-30 | Biomarck Pharmaceuticals Ltd | Egy fûtõrendszer mûködtetési eljárása, fûtõrendszer és felhasználásai |
| CN108686220A (zh) * | 2018-07-13 | 2018-10-23 | 刘慧荣 | 一种针对甲状腺癌的抗肿瘤剂 |
| EP4475866A4 (en) * | 2022-02-07 | 2026-02-25 | Park Strategic Ventures Llc | Peptides and their methods of use in the treatment of eye disorders |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501911B2 (en) | 1999-02-24 | 2013-08-06 | Biomarck Pharmaceuticals, Ltd | Methods of reducing inflammation and mucus hypersecretion |
| US7544772B2 (en) * | 2001-06-26 | 2009-06-09 | Biomarck Pharmaceuticals, Ltd. | Methods for regulating inflammatory mediators and peptides useful therein |
| US7265088B1 (en) | 2000-02-24 | 2007-09-04 | North Carolina State University | Method and compositions for altering mucus secretion |
| AU2002322475B2 (en) | 2001-06-26 | 2008-02-21 | North Carolina State University | Blocking peptide for inflammatory cell secretion |
| WO2003030827A2 (en) | 2001-10-05 | 2003-04-17 | The Trustees Of The University Of Pennsylvania | Compositions for and methods of treating and preventing sirs/sepsis |
| DE60308251T2 (de) | 2002-04-17 | 2007-08-30 | Canon K.K. | Vorrichtung zur Bereitstellung von öffentlichen Schlüsselzertifikaten |
| EP2399599A3 (en) | 2005-01-20 | 2012-04-18 | Biomarck Pharmaceuticals, Ltd. | Mucin hypersecretion inhibitors and methods of use |
| WO2006086681A2 (en) | 2005-02-09 | 2006-08-17 | Beth Israel Deaconess Medical Center, Inc. | Methods of inhibiting smooth muscle cell migration and proliferation |
| CN101516190B (zh) | 2006-07-26 | 2014-06-11 | 拜欧马克医药有限公司 | 减少炎症介质释放的方法和可用于该方法的肽 |
| WO2008127355A2 (en) * | 2006-10-06 | 2008-10-23 | Celtaxsys, Inc. | Chemorepulsion of cells |
| JP2010508512A (ja) | 2006-10-27 | 2010-03-18 | ジョージ メイソン インテレクチュアル プロパティーズ，インコーポレイテッド オブ フェアファックス，バージニア | 転移性結腸直腸癌のアッセイ |
| WO2009062128A2 (en) | 2007-11-08 | 2009-05-14 | Indiana University Research And Technology Corporation | Combination drug therapy for the treatment of cancer |
| EP2105511A1 (en) * | 2008-03-28 | 2009-09-30 | Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. | Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung |
| WO2011079015A1 (en) | 2009-12-21 | 2011-06-30 | The Regents Of The University Of California | Rgd-containing cyclic peptides |
| JP6225104B2 (ja) * | 2011-04-08 | 2017-11-01 | タフツ メディカル センター インコーポレイテッドＴｕｆｔｓ Ｍｅｄｉｃａｌ Ｃｅｎｔｅｒ，Ｉｎｃ． | ペプデューシンの設計および使用 |
| HUE043971T2 (hu) * | 2013-04-05 | 2019-09-30 | Biomarck Pharmaceuticals Ltd | Egy fûtõrendszer mûködtetési eljárása, fûtõrendszer és felhasználásai |
-
2014
- 2014-04-07 HU HUE14779844A patent/HUE043971T2/hu unknown
- 2014-04-07 SG SG11201508249WA patent/SG11201508249WA/en unknown
- 2014-04-07 EP EP14779844.1A patent/EP2981279B1/en active Active
- 2014-04-07 RU RU2015146997A patent/RU2681213C2/ru active
- 2014-04-07 SG SG10201708125PA patent/SG10201708125PA/en unknown
- 2014-04-07 CN CN201480031461.3A patent/CN105517562B/zh not_active Expired - Fee Related
- 2014-04-07 MX MX2015014036A patent/MX363077B/es unknown
- 2014-04-07 WO PCT/US2014/033206 patent/WO2014165853A1/en not_active Ceased
- 2014-04-07 JP JP2016506681A patent/JP6449849B2/ja not_active Expired - Fee Related
- 2014-04-07 ES ES14779844T patent/ES2714863T3/es active Active
- 2014-04-07 PL PL14779844T patent/PL2981279T3/pl unknown
- 2014-04-07 US US14/246,864 patent/US9408886B2/en active Active - Reinstated
- 2014-04-07 BR BR112015025398A patent/BR112015025398A2/pt not_active Application Discontinuation
- 2014-04-07 CA CA2908832A patent/CA2908832C/en active Active
- 2014-04-07 PT PT14779844T patent/PT2981279T/pt unknown
- 2014-04-07 KR KR1020157031658A patent/KR102191695B1/ko not_active Expired - Fee Related
- 2014-04-07 DK DK14779844.1T patent/DK2981279T3/en active
- 2014-04-07 AU AU2014247979A patent/AU2014247979B2/en not_active Ceased
-
2015
- 2015-10-06 IL IL241937A patent/IL241937B/en active IP Right Grant
- 2015-10-28 ZA ZA2015/08010A patent/ZA201508010B/en unknown
-
2016
- 2016-07-06 US US15/203,376 patent/US10011636B2/en active Active
-
2018
- 2018-06-04 US US15/996,797 patent/US10683328B2/en active Active - Reinstated
-
2020
- 2020-06-12 US US16/900,130 patent/US11466054B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015518818A5 (https=) | ||
| JP2019194251A5 (https=) | ||
| JP2017523985A5 (https=) | ||
| JP2013027391A5 (https=) | ||
| JP2012082206A5 (https=) | ||
| JP2015517488A5 (https=) | ||
| JP2012529293A5 (https=) | ||
| HRP20201081T1 (hr) | Inhibitorni peptidi porijeklom od trem-sličnog transkripta 1 (tlt-1) i njihove uporabe | |
| CN111788191A (zh) | 用于治疗癌症的1-(哌啶基羰基甲基)-2-氧代哌嗪衍生物 | |
| JP2016052315A5 (https=) | ||
| RU2017101667A (ru) | Фармацевтические композиции | |
| HRP20191852T1 (hr) | Polipeptidi | |
| JP2013503110A5 (https=) | ||
| RU2015119517A (ru) | Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1 | |
| JP2012115277A5 (https=) | ||
| JP2015519313A5 (https=) | ||
| RU2015112625A (ru) | Пептид, применение пептида для лечения сердечно-сосудистых заболеваний, нуклеотидная последовательность, вектор экспрессии, хозяйская клетка, фармацевтическая композиция | |
| RU2017119773A (ru) | Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение | |
| JP2018501791A5 (https=) | ||
| JP2015533791A5 (https=) | ||
| JP2019534884A5 (https=) | ||
| JP2020520677A5 (https=) | ||
| JP2016516756A5 (https=) | ||
| RU2020131372A (ru) | ИНГИБИТОРЫ микроРНК 22 | |
| RU2012157399A (ru) | Пептиды в качестве активных агентов для стабилизации биологических барьеров |